Skip To Main Content

Artikel

Sorter efter

Filtre

Nulstil
  • Terapiområde
Is Glycemic Control the Key to Preventing Long-term Complications in Type 2 Diabetes?

Is Glycemic Control the Key to Preventing Long-term Complications in Type 2 Diabetes?

(Based on the study: Stratton IM, et al. BMJ. 2000;321(7258):405-12).

The Complex Burden of Autoimmune Type 1 Diabetes

The Complex Burden of Autoimmune Type 1 Diabetes

Reflekter over ny tilgang til KOL

Reflekter over ny tilgang til KOL

At få en forståelse for type 2 inflammation* kan belyse hvorfor nogle KOL-patienter fortsætter med at få eksacerbationer. Se denne video og lær mere.1

Betydningen af type 2-inflammation*

Betydningen af type 2-inflammation

Livskvalitet og vurdering af symptomer hos KOL-patienter

Livskvalitet og vurdering af symptomer hos KOL-patienter

Betydningen af eksacerbationer ved KOL

Betydningen af eksacerbationer ved KOL

Uncovering the Hidden Burden: Understanding Loss of Smell in CRSwNP

Uncovering the Hidden Burden: Understanding Loss of Smell in CRSwNP

Navigating the Complexities of Smell Loss in Patients with CRSwNP.

Long-Term Efficacy and Safety of Dupixent in Moderate-to-Severe Atopic Dermatitis: 5-Year Open-Label Extension Study Results<sup>1</sup>

LIBERTY studieprogram på atopisk eksem

Atopic dermatitis (AD) is a chronic inflammatory skin condition that can significantly impact patients' quality of life. Dupixent (dupilumab) has emerged as a treatment for moderate-to-severe AD. This article summarizes the findings of a 5-year open-label extension study (Beck et al, 2024), providing insights into the long-term efficacy and safety profile of Dupixent for dermatologists managing patients with persistent AD.

Global Developments in Early Detection<br />of Autoimmune Type 1 Diabetes

Global Developments in Early Detection of Autoimmune Type 1 Diabetes

Curious about the characteristics of pre-symptomatic- and stage 3 Type 1 Diabetes? Interested in learning about the potential benefits of screening for autoimmune Type 1 Diabetes?

This short film gives you an overview of recent developments in diagnosis of Type 1 Diabetes, showcasing how early detection efforts can benefit those who need it the most.

Detectability of Autoimmune Type 1 Diabetes

Detectability of Autoimmune Type 1 Diabetes

Systematic early detection of autoimmune Type 1 Diabetes might be a new way to avoid acute and chronic complications of the condition.1-5 This new approach may play a role as a revolutionary shift, helping to shape the future of Type 1 Diabetes management.2

Infographic: Impact of Type 1 Diabetes Diagnosis

Infographic: Impact of Type 1 Diabetes Diagnosis

This infographic summarizes survey data* about the impact that families across the Nordic countries have felt when being diagnosed with autoimmune Type 1 Diabetes (T1D).

Time to Rethink T1D?

Time to Rethink T1D?

Start to think differently about Type 1 Diabetes by considering the pre-symptomatic stages of the condition and how it affects people of all ages and their families.